Page 61 - Sohini Das

Centre asks states to increase testing, vaccination amid recent Covid surge

Reviews Covid-19 situation in nine states where test positivity rates have been rising

Covaxin third shot gives long-term immunity: Nature Scientific study

Study shows booster jab is effective against several Sars-CoV-2 strains such as Alpha, Beta, Delta, Delta Plus and Omicron, and also increases memory B-cell response

Rupee at 80: Neutral impact for India's pharma industry, say experts

India's pharma sector exported drugs worth Rs 1.8 trillion in 2021-22, while APIs worth Rs 30,000 crore were imported

India's rising medical devices imports hurt small and medium units

China accounts for about one-fifth of FY22 numbers; 41% surge overall

Deal with Zoetis could be worth $500 mn in 10 yrs: Syngene In'l chief

In a Q&A, Jonathan Hunt, MD & CEO of the Biocon arm, dwells on his firm's initiatives to overcome supply chain bottlenecks and other issues

Slow and steady: India touches 2 billion Covid-19 vaccine doses milestone

Experts feel heterologous boosting and focus on drugs is the way forward

Coronavirus: First day of free boosters sees nearly 95% jump in offtake

1.49 mn booster doses administered out of total 2 mn doses given on Friday

Day-1 of free boosters: Citizens queue up to get jabs ahead of festivals

States start compiling need for additional doses, Centre seeks 50 mn doses from GAVI

Syngene International signs 10-year agreement with US-based firm Zoetis

Librela or bedinvetmab has already been launched in Europe and the UK, and has won 'Best new companion animal product' by IHS Markit Connect in 2021

Mylab launches combined RT-PCR test for Zika, malaria, dengue

Test can differentiate between seven diseases and give results in 2 hrs

NIM inclusion of anti-cancer vaccine may start with 9-14 year olds

The inclusion of this vaccine in the NIM is a significant step in reducing cervical cancer burden among women

Glenmark nasal spray cuts down viral load of Covid by 94% in 24 hrs

Glenmark had conducted the study on 306 vaccinated and unvaccinated adults with symptomatic mild Covid-19 disease across 20 clinical trial sites in India

India's 1st monkeypox case reported in Kerala; Centre sends high-level team

A person who returned to Kerala from abroad and was hospitalised after showing signs of monkeypox tested positive for the same, state Health Minister Veena George said on Thursday

Monkeypox: Health Ministry asks states to screen, isolate patients

The health ministry has asked states to start screening at points of entries, contact-tracing, and undertake surveillance activities following detection of a case

For the first time, Centre allows a private player to process opium

Bajaj Healthcare is the first private player to be awarded a tender to make alkaloids and APIs from opium gum

Free Covid precaution doses for 18-59 age group for 75 days at govt centres

Special drive to be held at govt centres; will reduce vaccine wastage

Cell-therapy treatment for cancer in India may come at 10% of US cost

Pharma companies and start-ups working to launch it within two years

Results preview: Pharma margins likely to remain under pressure in Q1

Hospitals back to normalcy; tough road ahead for diagnostics

Draft Bill 2022 seeks to regulate e-pharmacies and medical devices

Centre also proposes to have an expert group on medical devices

Bharat Biotech's Zika vaccine to enter Phase 2 clinical trials soon

In 2016, Big Pharma companies like Pfizer, Johnson & Johnson, and Merck were evaluating developing a Zika vaccine